In the AR-positive prostate cell line LNCaP, PMEPA1-b mediates AR protein degradation to inhibit prostate cancer proliferation in a proteasome-dependent manner by recruiting the E3 ubiquitin ligase NEDD4 (6, 31). Here, AR is linked to prostate carcinoma.